Detail page

Knowledge Web

Person

Enno Schmidt (1969-)

Name	Enno Schmidt
Time	1969- (Date of birth and death)
Place	Lübeck (Wirkungsort) Deutschland
Related	Universitätsklinikum Schleswig-Holstein
Further information	1. Diss. Medizinische Fakultät, 2. Diss. Philosophical Doctor (Ph. D.) Biotechnologie; Habil. Fach Dermatologie und Venerologie an der Medizinischen Fakultät Univ. Würzburg; Klinik für Dermatologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
Record type	Person
GND-Identifier	118148044
Record ID	118148044
Involved in show all Unbiased screening identifies regulators of cell-cell adhesion and treatment options in pemphigus Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomised controlled trial Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid = Laminin [Beta]4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology A life for autoimmune blistering diseases: in memoriam Detlef Zillikens S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large prospective cohort study The relevance of complement in pemphigoid diseases : A critical appraisal Untersuchungen zur relativen Häufigkeit von bullösen Autoimmundermatosen in einer multizentrischen prospektiven Studie Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of "Fogo Selvagem" Pemphigus Foliaceus COVID‐19 and implications for dermatological and allergological diseases COVID‐19 and implications for dermatological and allergological diseases Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update Resolution in bullous pemphigoid Mechanisms of Autoantibody-Induced Pathology Neue Aspekte zur Immunpathologie und Therapie blasenbildender Autoimmundermatosen Development of novel tools for the generation and detection of human monoclonal antibodies Zytokinvermittelte Immunmechanismen in der Pathogenese des bullösen Pemphigoids

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Enno Schmidt (1969-)

Unbiased screening identifies regulators of cell-cell adhesion and treatment options in pemphigus

Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomised controlled trial

Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid = Laminin [Beta]4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid

S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology

A life for autoimmune blistering diseases: in memoriam Detlef Zillikens

S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid

S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid

Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large prospective cohort study

The relevance of complement in pemphigoid diseases : A critical appraisal

Untersuchungen zur relativen Häufigkeit von bullösen Autoimmundermatosen in einer multizentrischen prospektiven Studie

Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of "Fogo Selvagem" Pemphigus Foliaceus

COVID‐19 and implications for dermatological and allergological diseases

COVID‐19 and implications for dermatological and allergological diseases

Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans

S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update

S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update

Resolution in bullous pemphigoid

Mechanisms of Autoantibody-Induced Pathology

Neue Aspekte zur Immunpathologie und Therapie blasenbildender Autoimmundermatosen

Development of novel tools for the generation and detection of human monoclonal antibodies

Zytokinvermittelte Immunmechanismen in der Pathogenese des bullösen Pemphigoids